1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


TABLE 2: 
Demographics
AttributeGrade III GliomasGlioblastoma
MeanSD95% CIMeanSD95% CI
Age40.414.136.4–45.254.914.352.0–57.8
KPS86.912.882.9–90.984.214.181.4–87
Survival (days)20102321560–246074860.6630–867
SexFemale, 52.4%Female, 34.5%
Male, 47.6%Male, 65.5%
OligodendrogliomaNoneMinorMajorNoneMinorMajor
Component (%)38.128.633.385.57.27.3
Resection (%)10090–9920–890–1910090–9920–890–19
16.626.231.026.233.723.526.516.3
  • Note.—KPS indicates Karnofsky performance status.